Inventor
HIRAWAT SAMIT
US19 patents
⚠️ This page may combine multiple inventors who share the name “HIRAWAT SAMIT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PTC THERAPEUTICS INC
10 patentsUS10172836B2Jan 8, 2019
Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation supression therapy
PTC THERAPEUTICS INC4 citations83
US10034863B2Jul 31, 2018
Compositions for an orally active 1,2,4-oxadiazole for the treatment of disease
PTC THERAPEUTICS INC5 citations83
US9877952B2Jan 30, 2018
Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy
PTC THERAPEUTICS INC6 citations83
US9737513B2Aug 22, 2017
Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy
PTC THERAPEUTICS INC6 citations83
US9522137B2Dec 20, 2016
Methods for dosing an orally active 1,2,4-Oxadiazole for nonsense mutation suppression therapy
PTC THERAPEUTICS INC8 citations83
US9474743B2Oct 25, 2016
Compositions for an orally active 1,2,4-oxadiazole for the treatment of disease
PTC THERAPEUTICS INC8 citations83
US10285980B2May 14, 2019
Compositions for an orally active 1,2,4-oxadiazole for the treatment of disease
PTC THERAPEUTICS INC1 citations72
US11497736B2Nov 15, 2022
Compositions for an orally active 1,2,4-oxadiazole for the treatment of disease
PTC THERAPEUTICS INC0 citations62
US10849885B2Dec 1, 2020
Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy
PTC THERAPEUTICS INC0 citations51
US10675272B2Jun 9, 2020
Compositions for an orally active 1,2,4-oxadiazole for the treatment of disease
PTC THERAPEUTICS INC0 citations51
CAO LIANGXIAN
3 patentsUS8076352B2Dec 13, 2011
Administration of carboline derivatives useful in the treatment of cancer and other diseases
CAO LIANGXIAN30 citations92
US8697662B2Apr 15, 2014
Methods for treating Kaposi sarcoma
CAO LIANGXIAN5 citations71
US8703726B2Apr 22, 2014
Methods for treating prostate conditions
CAO LIANGXIAN6 citations70
NOVARTIS AG
3 patentsUS10213432B2Feb 26, 2019
Dosage regimen for a PI-3 kinase inhibitor
NOVARTIS AG0 citations47
US10085996B2Oct 2, 2018
Pharmaceutical combinations
NOVARTIS AG0 citations47
US9913846B2Mar 13, 2018
Combination of a PI3 kinase inhibitor with pacitaxel for use in the treatment or prevention of a cancer of the head and neck
NOVARTIS AG0 citations45